Intravenous bisphosphonate therapy may lead to osteonecrosis of the jaw in multiple myeloma, breast, and prostate cancer patients.
Migliorati
Cesar A
CA
NSU College of Dental Medicine, 3200 S. University Drive, Fort Lauderdale, FL 33328, USA. migliora@nova.edu